| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/30/2003 | CA2482907A1 Tissue specific genes and gene clusters |
| 10/30/2003 | CA2482897A1 Two green fluorescent protein fragments and their use in a method for detecting protein - protein interactions |
| 10/30/2003 | CA2482769A1 "doping" in walk-through mutagenesis |
| 10/30/2003 | CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 10/30/2003 | CA2482719A1 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 10/30/2003 | CA2482597A1 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 10/30/2003 | CA2482477A1 Synthetic glyco-lipo-peptides as vaccines |
| 10/30/2003 | CA2482464A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 10/30/2003 | CA2482368A1 Cytokine receptor |
| 10/30/2003 | CA2481952A1 Immunological methods and compositions for the treatment of alzheimer's disease |
| 10/30/2003 | CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders |
| 10/30/2003 | CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/30/2003 | CA2481171A1 Hepatitis c virus assay systems |
| 10/30/2003 | CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/30/2003 | CA2480404A1 Fc receptor homolog, reagents, and uses thereof |
| 10/30/2003 | CA2427190A1 Production of recombinant epidermal growth factor in plants |
| 10/29/2003 | EP1357189A2 Elicitor of the hypersensitive response in plants |
| 10/29/2003 | EP1357188A1 Improvement of plant flower type targeting mads box gene |
| 10/29/2003 | EP1357187A1 Novel physiologically active peptide and use thereof |
| 10/29/2003 | EP1357186A1 Novel proteins and dnas thereof |
| 10/29/2003 | EP1357183A1 Rice sucrose transporter gene promoter |
| 10/29/2003 | EP1357181A1 Novel atopic dermatitis-associated gene and proteins |
| 10/29/2003 | EP1357130A1 Basic fibroblastic growth factor with a specific collagen binding domain |
| 10/29/2003 | EP1357129A2 Novel physiologically active peptide and use thereof |
| 10/29/2003 | EP1357128A1 The preparation and usage of plasmodium fusion antigen |
| 10/29/2003 | EP1357127A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
| 10/29/2003 | EP1356824A2 88KDA tumorigenic growth factor and antagonists |
| 10/29/2003 | EP1356350A1 Silver-dispersing polypeptides |
| 10/29/2003 | EP1356300A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 10/29/2003 | EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9 |
| 10/29/2003 | EP1356285A2 Differentially expressed epitopes and uses thereof |
| 10/29/2003 | EP1356284A2 Schizophrenia related genes |
| 10/29/2003 | EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 10/29/2003 | EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 10/29/2003 | EP1356099A2 Method and nucleic acids for the analysis of astrocytomas |
| 10/29/2003 | EP1356091A2 Method of detecting inflammatory lung disorders |
| 10/29/2003 | EP1356080A1 Detection and identification of groups of bacteria |
| 10/29/2003 | EP1356075A2 Protein scaffolds for antibody mimics and other binding proteins |
| 10/29/2003 | EP1356069A2 Enhanced transfection system |
| 10/29/2003 | EP1356068A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 10/29/2003 | EP1356066A2 Control of gene expression in plants |
| 10/29/2003 | EP1356064A2 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof |
| 10/29/2003 | EP1356061A2 Artificial transcriptional factors and methods of use |
| 10/29/2003 | EP1356060A2 Twin-arginine translocation in bacillus |
| 10/29/2003 | EP1356054A2 Bacillus thuringiensis proteins and vatiants thereof with pesticidal activity against coleopterans |
| 10/29/2003 | EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 10/29/2003 | EP1356051A2 Genes |
| 10/29/2003 | EP1356050A2 Fluorescent proteins |
| 10/29/2003 | EP1356049A2 Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof |
| 10/29/2003 | EP1356048A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 10/29/2003 | EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 10/29/2003 | EP1356046A2 Cytokine receptor zcytor19 |
| 10/29/2003 | EP1356045A2 Egf motif protein, egfl6 materials and methods |
| 10/29/2003 | EP1356044A2 32146 and 57259, novel human transporters and uses thereof |
| 10/29/2003 | EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 10/29/2003 | EP1356042A2 Carbohydrate-associated proteins |
| 10/29/2003 | EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/29/2003 | EP1356039A2 Down syndrome critical region 1-like 1 proteins |
| 10/29/2003 | EP1356038A2 Compositions and methods relating to lung specific genes and proteins |
| 10/29/2003 | EP1356036A2 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 10/29/2003 | EP1356034A2 Genes associated with allergic hypersensitivity and mast cell activation |
| 10/29/2003 | EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof |
| 10/29/2003 | EP1356028A2 Protein modification and maintenance molecules |
| 10/29/2003 | EP1356026A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 10/29/2003 | EP1356025A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 10/29/2003 | EP1356021A2 Method to remove citrate and aluminum from proteins |
| 10/29/2003 | EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 10/29/2003 | EP1355945A2 Flint glycoforms |
| 10/29/2003 | EP1355944A2 Rtvp based compositions and methods for the treatment of prostate cancer |
| 10/29/2003 | EP1355943A2 Neurotransmitter transporters |
| 10/29/2003 | EP1355942A2 Glp-1 fusion proteins |
| 10/29/2003 | EP1355941A2 Long lasting growth hormone releasing factor derivatives |
| 10/29/2003 | EP1355940A2 Urotensin-ii agonists and antagonists |
| 10/29/2003 | EP1355939A2 Interferons, uses and compositions related thereto |
| 10/29/2003 | EP1355937A2 Mammalian alpha-helical protein-53 |
| 10/29/2003 | EP1355936A2 Polymer conjugates of neublastin and methods of using same |
| 10/29/2003 | EP1355935A2 Secreted proteins |
| 10/29/2003 | EP1355934A2 Compositions and methods relating to lung specific genes and proteins |
| 10/29/2003 | EP1355933A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases |
| 10/29/2003 | EP1355932A2 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells |
| 10/29/2003 | EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 10/29/2003 | EP1355929A2 Basb209 polypeptides and polynucleotides from haemophilus influenzae |
| 10/29/2003 | EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 10/29/2003 | EP1355927A2 Identification of the anti-sigma-28 factor in helicobacter pylori, in campylobacter jejuni and in pseudomonas aeruginosa and application thereof |
| 10/29/2003 | EP1355926A2 Therapeutic compounds for ovarian cancer |
| 10/29/2003 | EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 10/29/2003 | EP1355924A2 Armed peptides |
| 10/29/2003 | EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 10/29/2003 | EP1355922A2 Stress proteins and peptides and methods of use thereof |
| 10/29/2003 | EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 10/29/2003 | EP1355919A2 Molecules with extended half-lives, compositions and uses thereof |
| 10/29/2003 | EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 10/29/2003 | EP1355917A2 Compositions and methods relating to breast specific genes and proteins |
| 10/29/2003 | EP1355668A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 10/29/2003 | EP1355666A2 Use of rgm and its modulators |
| 10/29/2003 | EP1355662A2 Method of preventing t cell-mediated responses by the use of the major histocompatibility complex class ii analog protein (map protein) from staphylococcus aureus |
| 10/29/2003 | EP1355657A2 Gssp3 polynucleotides and polypeptides and uses thereof |
| 10/29/2003 | EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
| 10/29/2003 | EP1355655A2 Compositions and methods for improving kidney function |
| 10/29/2003 | EP1355529A2 Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety |